(FILES) A picture taken on June 9, 2013, shows the logo of Israel's drug maker Teva Pharmaceutical Industries at the Teva Pharma France headquarters in La Defense business district, west of Paris. The European Commission imposed a fine of 462,6 million euros on Israeli pharmaceutical group Teva on October 31, 2024, accusing it of "abuse of a dominant position" for its multiple sclerosis treatment Copaxone. (Photo by Lionel BONAVENTURE / AFP) (Photo by LIONEL BONAVENTURE/AFP via Getty Images)